Cost management solutions company Tempus Innovations partnered with Regenexx to provide reduced-cost, non-surgical treatments to injured workers. By Jackie Drees - 9/21/18

Here are 10 key players in the global orthopedic biomaterials market, according to a Market iFrame report. By Shayna Korol - 9/20/18

MIACH Orthopaedics, a bioengineered surgical implant company, completed $22.5 million in financing. By Shayna Korol - 9/17/18

UC San Diego researchers derived spinal cord neural stem cells from human pluripotent stem cells transplanted  into a rat model with spinal cord injury, according to a study in Nature Methods. By Shayna Korol - 9/14/18

University of Toledo (Ohio) researchers developed a smart injectable calcium phosphate bone cement for orthopedic and spinal fusion applications. The smart CaP compositions were biocompatible, according to a study in Materials. By Shayna Korol - 9/13/18

Best in Class Care entered an agreement with Regenexx to reduce high-cost musculoskeletal surgeries and accelerate employers' ability to directly contract with its network of providers. By Jackie Drees - 9/12/18

The Seattle Regenerative Medicine Center opened a new location in Bellevue, Wash. By Shayna Korol - 9/7/18

Baxter International received FDA clearance for its Actifuse Flow bone graft substitute. By Shayna Korol - 9/6/18

Mark Mikhael, MD, is studying the use of proteins from donor stem cells in spinal fusion surgery, Chicago Health reports. By Shayna Korol - 9/5/18

Market analysts predict the spine biologics market will top $2.6 billion by 2022, growing at a 4.4 percent compound annual growth rate, according to a Market Research Engine report. By Mackenzie Garrity - 9/4/18

SpinalCyte received a U.S. patent for its cartilage repair technology using an in vivo bioreactor. By Shayna Korol - 8/30/18

While the use of biologics in spine surgery is still emerging, more spine surgeons are gaining exposure to the field as new clinical trials and noninvasive treatments are born. By Mackenzie Garrity - 8/29/18

InVivo Therapeutics released the 12-month results of its investigational study of the Neuro-Spinal Scaffold to treat acute thoracic complete spinal cord injury. By Shayna Korol - 8/28/18

Avista Healthcare Public Acquisition will merge with the regenerative medicine company Organogenesis. By Shayna Korol - 8/27/18

Isto Biologics is an orthobiologics company that develops spine and orthopedic solutions. By Shayna Korol - 8/22/18

Axial spondyloarthritis patients who received biologics-based treatment had less work and activity impairment than patients who did not receive biologics, according to a study in the Annals of the Rheumatic Diseases. By Shayna Korol - 8/21/18

Dr. Jonathan Hopper joined Vericel Corp., as the company's new CMO. By Jackie Drees - 8/20/18

The global spine biologics market is expected to grow at a 4.4 percent compound annual growth rate to reach more than $2.6 billion by 2022, according to a Market Research Engine report. By Shayna Korol - 8/20/18

Paragon 28 released its bone graft harvesting system, which is designed to improve foot and ankle surgical outcomes. By Jackie Drees - 8/16/18

BioRestorative Therapies' study, which evaluates the benefits of long-term hypoxic culturing of human bone marrow-dervied mesenchymal stem cells to treat disc and spine diseases, was published in the Journal of Translational Medicine. By Jackie Drees - 8/16/18